Print
Health Care

PPD Collaborates With Biopharma Company On Oncology, Immunology Therapies

By Christina Haley O'Neal, posted Aug 28, 2019
Wilmington-based Pharmaceutical Product Development (PPD) recently announced its collaboration with a global clinical-stage biopharmaceutical company to develop oncology and immunology therapeutics.

Harbour BioMed (HBM) has selected PPD as its preferred global contract research partner to conduct clinical studies on its internal research pipelines, according to a news release.

The company is using PPD Biotech services, which, according to its website, finds phase I through IV clinical development solutions for biotech and small to midsize pharmaceutical companies.

The two companies recently completed an Australian ethics committee submission for HBM’s anti-cancer immunotherapy to target solid tumors, stated the release. They reached a milestone ahead of schedule, “on the path to Phase I trials in Australia and the United States,” according to the release.

“Our enthusiasm for the opportunity to support the development of HBM’s innovative assets is equaled by our shared commitment to helping accelerate the delivery of life-changing therapies to patients,” Anshul Thakral, executive vice president and global head of PPD Biotech, said in the release.

PPD Biotech was formed several years ago, and in the past five years, has worked with more than 270 biotech and small pharma clients on more than 650 studies, a PPD spokesperson said in an email Wednesday.

“Harbour BioMed’s selection of PPD Biotech as its preferred partner is further evidence that pairing our unique biotech perspective with our scalable global development services is a powerful combination for our customers," Thakral said. "Collaborating with experts at Harbour BioMed in the early stages of its product development enabled our seasoned medical and operational oncology leaders to offer the right tailored, forward-thinking strategy."

HBM has been developing a “robust pipeline in oncology and immunology” since it was established in 2016, stated the release. The company, which is a clinical-stage biopharma company developing therapeutics in the fields of immuno-oncology and inflammatory diseases, has operations in Cambridge, Massachusetts, The Netherlands and China.

“I’m pleased that our collaborative partnership already has enabled us to achieve the important milestone of our first global [ethics committee] submission, and ahead of our aggressive schedule. We look forward to entering the clinical trial phase of our development programs with PPD as we pursue our global vision and ambition of delivering next-gen therapeutics to fulfill patient needs around the world,” Jingsong Wang, founder, chairman and CEO of HBM, said in the release.
Ico insights

INSIGHTS

SPONSORS' CONTENT
Carolinemontgomery4

Found Money: Tax Extenders And Disaster Relief

Caroline Montgomery - Adam Shay CPA, PLLC
Lyleheadshot2017 1251720228

The Key To Fundraising Success

JC Lyle - Wilmington Area Rebuilding Ministry
Lynnwhitecell hwconsulting headshot

7 Tips For Delegating Better

Lynn Whitesell - Harris Whitesell Consulting

Trending News

ILM Lands Boston Flight, Reaches 1M Passengers

Christina Haley O'Neal - Jan 14, 2020

Local Firm To Be Considered For Redevelopment Of Government Center

Cece Nunn - Jan 15, 2020

Big Sky Design Moving To Oleander Drive

Cece Nunn - Jan 14, 2020

Developers Plan Modern Industrial Building In Pender

Christina Haley O'Neal - Jan 15, 2020

Wrightsville Beach Brewery Plans Facility In Leland

Jessica Maurer - Jan 15, 2020

In The Current Issue

A Matter Of School Days For Tourism

Although the school calendar is staying the same for now for New Hanover County schools, it’s an ongoing issue that tourism and educators gr...


Info Junkie: Zane S. Bennett

Zane Bennett, executive director of Plantation Village, shares his top info and tech picks....


Real Estate Runs In The Family

Real estate firms often include multiple generations working alongside each other, and examples abound in the Wilmington area....

Book On Business

The 2019 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!


Galleries

Videos

2019 Health Care Heroes
August 26, 2019 Power Breakfast: A Healthy Sale?
2019 WILMA Leadership Accelerator
2019 WilmingtonBiz Expo Keynote Lunch - CEO, nCino, Pierre Naude`